Geovax to participate in the 3rd annual roth healthcare opportunities conference

Atlanta, ga., oct. 02, 2024 (globe newswire) -- geovax labs, inc. (nasdaq: govx), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced that its chairman & ceo, david dodd, will participate in a panel discussion on innovative therapies for solid tumors at the 3rd annual roth healthcare opportunities conference taking place on october 9, 2024 in new york, ny. senior geovax management will also host one-on-one meetings with registered attendees.
GOVX Ratings Summary
GOVX Quant Ranking